Nakanishi Resultados de beneficios anteriores

Pasado controles de criterios 5/6

Nakanishi ha aumentado sus ingresos a un ritmo medio anual de 21.6%, mientras que la industria Medical Equipment ha visto aumentar sus ingresos growing a 7.8% anualmente. Los ingresos han crecido growing a un ritmo medio anual de 9.8%. Nakanishi La rentabilidad de los fondos propios de la empresa es de 21.1% y sus márgenes netos son de 45.8%.

Información clave

25.8%

Tasa de crecimiento de los beneficios

26.3%

Tasa de crecimiento del BPA

Crecimiento de la industria Medical Equipment	7.8%
Tasa de crecimiento de los ingresos	11.3%
Rentabilidad financiera	20.2%
Margen neto	38.3%
Próxima actualización de resultados	10 May 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Nakanishi. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

TSE:7716 Ingresos, gastos y beneficios (JPY Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Dec 23	59,692	22,835	19,924
30 Sep 23	53,788	24,647	18,418
30 Jun 23	52,468	13,824	17,414
31 Mar 23	50,305	12,634	16,310
31 Dec 22	48,671	12,471	15,005
30 Sep 22	47,488	12,214	14,675
30 Jun 22	46,305	11,486	13,931
31 Mar 22	45,501	10,170	13,253
31 Dec 21	44,857	10,102	12,845
30 Sep 21	44,243	10,658	11,706
30 Jun 21	42,380	9,963	11,285
31 Mar 21	37,096	9,087	10,514
31 Dec 20	33,055	6,455	10,471
30 Sep 20	31,588	6,105	10,683
30 Jun 20	31,853	5,935	10,886
31 Mar 20	34,445	5,931	11,464
31 Dec 19	35,418	7,102	11,727
30 Sep 19	35,315	6,418	11,992
30 Jun 19	34,897	6,254	11,905
31 Mar 19	35,616	7,324	11,736
31 Dec 18	36,543	7,588	11,345
30 Sep 18	36,590	8,261	11,095
30 Jun 18	36,791	8,400	10,813
31 Mar 18	35,756	7,550	10,890
31 Dec 17	34,341	7,341	10,734
30 Sep 17	33,769	6,389	10,994
30 Jun 17	32,672	6,031	10,897
31 Mar 17	31,974	5,661	10,580
31 Dec 16	31,829	5,297	10,310
30 Sep 16	31,867	5,788	9,919
30 Jun 16	32,050	5,662	9,936
31 Mar 16	31,944	5,864	9,862
31 Dec 15	31,862	6,203	9,772
30 Sep 15	31,186	6,208	9,873
30 Jun 15	30,838	6,911	9,594
31 Mar 15	30,446	6,980	9,291
31 Dec 14	30,908	6,965	9,244
30 Sep 14	30,204	6,240	8,928
30 Jun 14	29,147	5,582	8,713
31 Mar 14	28,506	5,220	8,434
31 Dec 13	26,236	4,735	7,987
30 Sep 13	24,523	4,611	7,544
30 Jun 13	23,215	4,204	7,159

Ingresos de calidad: 7716 tiene un alto nivel de ganancias no monetarias.

Margen de beneficios creciente: 7716Los actuales márgenes de beneficio netos de (38.3%) son superiores a los del año pasado (25.6%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: 7716En los últimos 5 años, los beneficios de la empresa han crecido significativamente: 21.6% al año.

Acelerando crecimiento: 7716El crecimiento de los beneficios de la empresa en el último año (83.1%) supera su media de 5 años (25.8% al año).

Beneficios vs. Industria: 7716 El crecimiento de los beneficios en el último año (83.1%) superó al del sector Medical Equipment 4.1% .

Rentabilidad financiera

Alto ROE: 7716(20.2%) se considera alta.

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Nakanishi Resultados de beneficios anteriores

Pasado controles de criterios 5/6

Información clave

Actualizaciones de resultados anteriores recientes

Nakanishi Inc. to Report Q1, 2024 Results on May 10, 2024

Full year 2023 earnings: EPS exceeds analyst expectations

Nakanishi Inc. to Report Fiscal Year 2023 Results on Feb 13, 2024

Third quarter 2023 earnings released: EPS: JP¥167 (vs JP¥40.41 in 3Q 2022)

Nakanishi Inc. to Report Q3, 2023 Results on Nov 10, 2023

Second quarter 2023 earnings released: EPS: JP¥56.46 (vs JP¥42.02 in 2Q 2022)

Recent updates

Final dividend of JP¥26.00 announced

Here's Why Nakanishi (TSE:7716) Can Manage Its Debt Responsibly

Now 21% undervalued after recent price drop

Consensus EPS estimates fall by 21%

Does Nakanishi (TSE:7716) Deserve A Spot On Your Watchlist?

Nakanishi Inc. to Report Q1, 2024 Results on May 10, 2024

Nakanishi Inc. (TSE:7716) announces an Equity Buyback for 1,100,000 shares, representing 1.17% for ¥2,000 million.

New major risk - Earnings quality

Now 21% overvalued

Full year 2023 earnings: EPS exceeds analyst expectations

Nakanishi Inc. Provides Earnings Forecast for the First Half and Fiscal Year Ending December 31, 2024

Price target decreased by 11% to JP¥3,595

Upcoming dividend of JP¥26.00 per share at 2.2% yield

Nakanishi Inc. to Report Fiscal Year 2023 Results on Feb 13, 2024

Consensus EPS estimates increase by 21%, revenue downgraded

New minor risk - Share price stability

Third quarter 2023 earnings released: EPS: JP¥167 (vs JP¥40.41 in 3Q 2022)

Nakanishi Inc. Revises Earnings Forecast for the Fiscal Year Ending December 31, 2023

Now 20% undervalued after recent price drop

Price target increased by 9.9% to JP¥4,060

Nakanishi Inc. to Report Q3, 2023 Results on Nov 10, 2023

Nakanishi Inc. Revises Financial Guidance for the Fiscal Year Ending Dec. 31, 2023

Second quarter 2023 earnings released: EPS: JP¥56.46 (vs JP¥42.02 in 2Q 2022)

Nakanishi Inc. (TSE:7716) announces an Equity Buyback for 1,000,000 shares, representing 1.18% for ¥2,500 million.

Upcoming dividend of JP¥24.00 per share at 1.5% yield

Nakanishi Inc. to Report Q2, 2023 Results on Aug 07, 2023

First quarter 2023 earnings released: EPS: JP¥38.83 (vs JP¥36.49 in 1Q 2022)

Nakanishi Inc. Provides Earnings Guidance for First Half and Full Year of Year Ending March 31, 2024

Now 20% undervalued

Full year 2022 earnings: EPS exceeds analyst expectations

Nakanishi Inc. Provides Dividend Guidance for the Year Ending December 31, 2023

Nakanishi Inc., Annual General Meeting, Mar 30, 2023

Now 22% undervalued after recent price drop

Upcoming dividend of JP¥22.00 per share

Now 21% undervalued after recent price drop

Nakanishi Inc. to Report Fiscal Year 2022 Results on Feb 09, 2023

Price target increased to JP¥3,483

Third quarter 2022 earnings released: EPS: JP¥40.41 (vs JP¥31.52 in 3Q 2021)

Third quarter 2022 earnings released: EPS: JP¥40.41 (vs JP¥31.52 in 3Q 2021)

Nakanishi Inc. (TSE:7716) announces an Equity Buyback for 480,000 shares, representing 0.56% for ¥1,000 million.

Now 21% undervalued

Nakanishi Inc. to Report Q3, 2022 Results on Nov 11, 2022

Second quarter 2022 earnings released: EPS: JP¥42.02 (vs JP¥26.45 in 2Q 2021)

Nakanishi Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2022

Consensus revenue estimates increase by 12%

Nakanishi Inc. Announces Establishment of Nomination and Remuneration Committee

Upcoming dividend of JP¥20.00 per share

Nakanishi Inc. to Report Q2, 2022 Results on Aug 09, 2022

Consensus forecasts updated

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Nakanishi Inc. (TSE:7716) announces an Equity Buyback for 500,000 shares, representing 0.58% for ¥1,000 million.

No independent directors

Nakanishi Inc. to Report Q1, 2022 Results on May 12, 2022

Nakanishi Inc. (JASDAQ:7716) announces an Equity Buyback for 250,000 shares, representing 0.29% for ¥500 million.

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Nakanishi Inc., Annual General Meeting, Mar 30, 2022

Upcoming dividend of JP¥17.00 per share

Third quarter 2021 earnings released: EPS JP¥31.52 (vs JP¥23.48 in 3Q 2020)

Price target increased to JP¥2,965

Second quarter 2021 earnings released: EPS JP¥26.45 (vs JP¥16.34 in 2Q 2020)

Nakanishi Inc. (JASDAQ:7716) announces an Equity Buyback for 600,000 shares, representing 0.69% for ¥1,200 million.

Upcoming dividend of JP¥17.00 per share

Price target increased to JP¥2,815

First quarter 2021 earnings released: EPS JP¥35.47 (vs JP¥5.10 in 1Q 2020)

Nakanishi (TYO:7716) May Have Issues Allocating Its Capital

Full year 2020 earnings released: EPS JP¥74.49 (vs JP¥81.97 in FY 2019)

Is Nakanishi Inc. (TYO:7716) A Smart Choice For Dividend Investors?

Price target raised to JP¥2,400

Analysts increase EPS estimates to JP¥76.55

Desglose de ingresos y gastos
Beta